TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 69.90
+3.15 (4.72%)
At close: Mar 27, 2026
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 27.89 billion as of March 27, 2026.
Market Cap
27.89B
Enterprise Value
27.19B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
69.90
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 27.89B, an increase of 199.02%. That is a compound annual growth rate of 325.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 26.63B | -41.60% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 38.51B |
| Shanghai Henlius Biotech | 36.50B |
| Shanghai Junshi Biosciences | 33.84B |
| InnoCare Pharma | 25.04B |
| Genscript Biotech | 24.07B |
| Duality Biotherapeutics | 23.72B |
| PegBio | 23.70B |
| Keymed Biosciences | 16.95B |